Fundus Autofluorescence, Fluorescein Angiography and Spectral Domain Optical Coherence Tomography Findings of Retinal Astrocytic Hamartomas in Tuberous Sclerosis

Purpose: To analyze the structural and morphological characteristics of retinal astrocytic hamartomas in tuberous sclerosis patients using fundus autofluorescence, fluorescein angiography and spectral-domain optical coherence tomography. Case summary: Fundus examination, fundus autofluorescence, fluorescein angiography and spectral-domain optical coherence tomography were performed in three patients with tuberous sclerosis and the morphological and structural characteristics of retinal astrocytic hamartomas were analyzed. In the fundus autofluorescence, type 1 retinal astrocytic hamartoma showed hypofluorescence and type 3 showed central hyperfluorescence and surrounding hypofluorescence. Spectral domain optical coherence tomography showed dome-shaped hyper-reflectivity within the nerve fiber layer and focal adhesion of the vitreous cortex in the type 1 retinal astrocytic hamartoma. No abnormalities were observed in the outer retinal layer and retinal pigment epithelium. In the type 3 retinal astrocytic hamartoma, optical coherence tomography showed disorganization of retinal tissue and posterior shadowing. Intratumoral cavitation and moth-eaten appearance caused by intratumoral calcification were observed and the vitreous cortex adhered to the top of the tumor and showed traction. Retinal arterial sheathing was observed in all cases and hyper-reflectivity of the arterial wall was noted on optical coherence tomography. Conclusions: Fundus autofluorescence, fluorescein angiography and spectral-domain optical coherence tomography are helpful for the classification and diagnosis of retinal astrocytic hamartomas found in tuberous sclerosis patients as well as for differentiation from other lesions. J Korean Ophthalmol Soc 2016;57(1):134-140

[1]  J. Nyboer,et al.  Retinal lesions in tuberous sclerosis. , 1976, Archives of ophthalmology.

[2]  M. Larsen,et al.  Optical coherence tomography of astrocytic hamartomas in tuberous sclerosis. , 2006, Acta ophthalmologica Scandinavica.

[3]  D. Robertson.  Ophthalmic Manifestations of Tuberous Sclerosis , 1991, Annals of the New York Academy of Sciences.

[4]  J. Osborne,et al.  Epidemiology of Tuberous Sclerosis , 1991, Annals of the New York Academy of Sciences.

[5]  J. Augsburger,et al.  Exudative retinal detachment due to small noncalcified retinal astrocytic hamartoma. , 2003, American journal of ophthalmology.

[6]  K. Shinoda,et al.  Diagnosis of an isolated retinal astrocytic hamartoma aided by optical coherence tomography , 2008, Acta ophthalmologica.

[7]  S. Tsang,et al.  Infrared imaging and optical coherence tomography reveal early-stage astrocytic hamartomas not detectable by fundoscopy. , 2012, American journal of ophthalmology.

[8]  J. Osborne,et al.  Ophthalmic manifestations of tuberous sclerosis: a population based study , 2001, The British journal of ophthalmology.

[9]  C. Shields,et al.  Retinal pigment epithelial depigmented lesions associated with tuberous sclerosis complex. , 2012, Archives of ophthalmology.

[10]  C. Shields,et al.  Optical coherence tomography of retinal astrocytic hamartoma in 15 cases. , 2006, Ophthalmology.

[11]  S. Mennel,et al.  Autofluorescence and Angiographic Findings of Retinal Astrocytic Hamartomas in Tuberous Sclerosis , 2005, Ophthalmologica.

[12]  M. Gomez,et al.  Tuberous sclerosis: reappraisal of a clinical entity. , 1967, Mayo Clinic proceedings.

[13]  B. Ghosh,et al.  Spectral-domain optical coherence tomography of astrocytic hamartomas in tuberous sclerosis , 2012, International Ophthalmology.